Filing Details
- Accession Number:
- 0000904454-14-000608
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-29 19:31:27
- Reporting Period:
- 2014-08-27
- Filing Date:
- 2014-08-29
- Accepted Time:
- 2014-08-29 19:31:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1457612 | Genocea Biosciences Inc. | GNCA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591874 | Paul Giannasca | C/O Genocea Biosciences, Inc. 100 Acorn Park Drive, 5Th Floor Cambridge MA 02140 | Vp Of Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-27 | 1,303 | $2.86 | 1,303 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-27 | 1,303 | $12.77 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-28 | 4,602 | $2.86 | 4,602 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-28 | 4,602 | $12.36 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-29 | 855 | $2.86 | 855 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-29 | 855 | $12.86 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-27 | 1,303 | $0.00 | 1,303 | $2.86 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-28 | 4,602 | $0.00 | 4,602 | $2.86 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-29 | 855 | $0.00 | 855 | $2.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,012 | 2020-02-17 | No | 4 | M | Direct | |
| 18,410 | 2020-02-17 | No | 4 | M | Direct | |
| 17,555 | 2020-02-17 | No | 4 | M | Direct |
Footnotes
- The option vested 25% on January 25, 2011 and the remainder vested in equal monthly installments for the next three years thereafter.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.70 to $12.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.48. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.85 to $12.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
